NS Pharma is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd., committed to advancing revolutionary rare disease therapies that address unmet needs and help people live happier, healthier lives.
We serve as an in-house research center of excellence, as well as a first-class commercialization partner to clinical-stage biotechnology companies, driving life-changing scientific innovation forward.
PERSONALIZED SUPPORT
Our award-winning patient services illustrate our promise to provide dedicated partnership, driving equitable access and supporting the unique needs of every patient.
NS Pharma teams go above and beyond to ensure patients can access services and treatment, serving as the primary point of contact for families navigating the healthcare system.
BOLD INNOVATION
At NS Pharma we delve deeper to bring products to market that add demonstrable value to the community. Our dedicated team of pioneering scientists is advancing the frontiers of exon-skipping technology.
In our relentless pursuit of groundbreaking exon-skipping therapies, NS Pharma has developed a uniquely optimized approach to drug discovery. This proprietary process identifies the highest possible exon-skipping efficiency through a systematic screening process.
Our passionate relationships with patients, caregivers, advocacy groups, and healthcare professionals are critical to effectively addressing unmet needs, understanding the integrated patient journey and seizing opportunities for furthering impactful innovation.
